Skip to main content
OpenTrials
Completed

NCT Number: NCT05540444

RadConnect Communication Application

The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on productivity and well-being. A novel communication app was developed that streamlines communication between technologists and radiologists: RadConnect.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Communication Behavior

Sex eligibility

All sexes

Study type

Observational

Primary location

Leiden University Medical Center (LUMC)

Leiden, 2333 ZA, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals that are employed by LUMC
  • Individuals that are radiologists, radiology fellows, radiology residents, radiology technologists, doctor assistants, physician assistants or other support personnel in the Department of Radiology that raise managing image acquisition related questions.
  • Individuals that consent to participating in the study.
  • Individuals scheduled to work at locations at Sending Extensions, Receiving Extensions and Control Extensions.

Exclusion criteria

  • Individuals not able to understand or not willing to sign the informed consent form.
  • Individuals that indicate that they do no comprehend RadConnect and/or its intended use after two educational sessions.
  • Individuals not able to not willing to comply with the intended use of RadConnect.

Treatment and study plan

RadConnect

Device

The study will be performed in a clinical setting at the department of radiology of LUMC, meaning that we aim to test the hypothesis that ("RadConnect") can reduce the number of phone calls from a select set of extension used by technologists (the "Sending Extensions") to another select set of extensions manned by radiologists ("Receiving Extensions").

Primary outcomes

  1. Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists.

    Time frame: Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.

    • P1 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in Before Phase
    • P2 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase

    The primary endpoint will be obtained by testing the hypothesis that P1 > P2 using Wilcoxon's one-tailed test with significance level P < 0.05.

Secondary outcomes

  1. Compare experiences and attitudes of technicians and radiologists towards RadConnect versus phone calls.

    Time frame: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.

    • C1 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in Before Phase
    • C2 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in After Phase

    The first secondary endpoint will be obtained by testing the hypothesis that C1 ≠ C2 using Wilcoxon's two-tailed test with significance level P < 0.05.

  2. Measure the characteristics of technician questions raised over phone and through RadConnect.

    Time frame: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.

    • R2 = Mean number of completed RadConnect consultations per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase

    The second secondary endpoint will be obtained by testing the hypothesis that P1 ≠ P2 + R2 using Wilcoxon's two-tailed test with significance level P < 0.05.

  3. Consolidated opinion usability and experience of RadConnect in itself and in comparison to alternative communication methods.

    Time frame: 1 hour, after completion of the after phase (phase 2 of this study)

    The third secondary endpoint will be obtained by aggregating survey responses. In the structured online survey, if more than half of the respondents indicate that they prefer communication over RadConnect to calling, it will be concluded that RadConnect is a viable alternative to calling. If more than half of radiologist respondents indicate that they believe RadConnect helps them avoid interruptions, it will be concluded that RadConnect is a viable alternative to calling that may help reduce radiologist interruptions. The opinions of study participants are captured as Likert scale response and averaged to obtain a consolidated opinion. The consolidated responses are visualized as histograms.

Sponsors and collaborators

Lead sponsor

Philips Electronics Nederland B.V. acting through Philips CTO organization

Industry

Collaborators

  • Leiden University Medical Center

Registry information

Acronym: RadConnect

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Sep 14, 2022
Registry last updated
Jul 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.